US Patent 8124066 Methods of using interleukin-2 mutants with reduced toxicity
Patent 8124066 was granted and assigned to University of Southern California on February, 2012 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
September 22, 2010
Date of Patent
February 28, 2012
Patent Application Number
12888315
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 8124066 Methods of using interleukin-2 mutants with reduced toxicity
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
